İlyas Kaya
Research Subjects
İlyas Kaya has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Abdurrahman Akyüz
Department of Cardiology, University of Health Sciences, Diyarbakır Gazi Yaşargil Training and Research Hospital, Diyarbakir, Turkey
3 shared publications - Bernas Altıntaş
Department of Cardiology, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey
2 shared publications - Burhan Aslan
Department of Cardiology Health Science University Bursa City Hospital Bursa Turkey
2 shared publications - Ferhat Işık
University of Health Sciences, Gazi Yaşargil Training and Research Hospital, Department of Cardiology, Diyarbakır, Turkey
2 shared publications - Mehmet Şahin Adıyaman
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, DİYARBAKIR GAZİ YAŞARGİL SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZ
2 shared publications - Murat Çap
Department of Cardiology, University of Health Sciences Diyarbakir Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey
2 shared publications
Latest Publications
- Open Access
- 19 December 2022
- Published by Dicle Medical Journal/Dicle Tip Dergisi in Dicle Tıp Dergisi
- Vol. 49 (4) , 692-698
Miyokard Enfarktüsü Hastalarında Nesfatin Düzeyi ve NesfatininTroponin ve CRP ile Korelasyonu
Amaç: Miyokard enfarktüsü (MI), kardiyovasküler hastalık kaynaklı mortalite ve morbiditenin başlıca sebeplerindendir. Aterosklerotik plak rüptürü sonucu gelişen akut tromboz en önemli nedendir. Gıda alımı ve enerji homeostazında etkili olan nesfatin araştırılan belirteçlerdendir. Çalışmamızda miyokard enfarktüsü ile nesfatin düzeyi arasındaki ilişkiyi tespit etmeyi amaçladık. Ayrıca nesfatin düzeyinin troponin ve CRP ile ilişkisini açıklamayı planladık. Yöntemler: Etik kurul onayı alınarak yapılan çalışmamıza, yeni tanı almış ve yatırılarak koroner anjiografi yapılmış akut koroner sendrom (AKS) hastaları dahil edildi. Obezite, kronik böbrek hastalığı, diabetes mellitus hastalığı olanlar dışlandı. Kontrol grubuna troponin değerleri yükselmeyen ve normal koroner anatomi tespit edilen 60 hasta dahil edildi. MI grubunda başvuru Ekg’sinde>2 mm st segment elevasyonu görülerek primer perkütan girişim yapılan 59 MI hastası değerlendirildi. Tüm hastalarda demografik bilgiler, hemogram, serum nesfatin, troponin, c-reaktif protein (CRP), lipid paneli ve diğer rutin biyokimyasal parametreler bakıldı. SPSS 22 istatistik paket programı kullanıldı. Bulgular: MI grubunda troponin, LDL, CRP, WBC değerleri anlamlı düzeyde yüksek izlendi (p<0,001). Nesfatin değerlerinin kontrol grubuna göre anlamlı düzeyde düşük olduğu görüldü (p<0.001). Erkek cinsiyetin MI grubunda ağırlıkta olduğu görüldü. MI grubundaki verilerde yapılan korelasyon analizinde nesfatin ile troponin, lipid profili, CRP ve WBC arasında pozitif veya negatif yönde anlamlı herhangi bir korelasyon ilişkisi görülmedi. Sonuç: Çalışmamızda, düşük serum nesfatin seviyelerinin MI ile ilişkili olabileceği gösterilmiş ve etyopatogenetik sebeplerden biri olabileceği desteklenmiştir. Artmış troponin, LDL, CRP ve WBC düzeyleri ile herhangi bir korelasyon ilişkisi tespit edilmemiştir. Bu ilişki, inflamatuar özellikleri ve hastalığın prognozunu göstermesi açısından destekleyici olmamıştır.
- 19 December 2022
- Published by Dicle Medical Journal/Dicle Tip Dergisi in Dicle Tıp Dergisi
- Vol. 49 (4) , 692-698
Open AccessMiyokard Enfarktüsü Hastalarında Nesfatin Düzeyi ve NesfatininTroponin ve CRP ile Korelasyonu
Amaç: Miyokard enfarktüsü (MI), kardiyovasküler hastalık kaynaklı mortalite ve morbiditenin başlıca sebeplerindendir. Aterosklerotik plak rüptürü sonucu gelişen akut tromboz en önemli nedendir. Gıda alımı ve enerji homeostazında etkili olan nesfatin araştırılan belirteçlerdendir. Çalışmamızda miyokard enfarktüsü ile nesfatin düzeyi arasındaki ilişkiyi tespit etmeyi amaçladık. Ayrıca nesfatin düzeyinin troponin ve CRP ile ilişkisini açıklamayı planladık. Yöntemler: Etik kurul onayı alınarak yapılan çalışmamıza, yeni tanı almış ve yatırılarak koroner anjiografi yapılmış akut koroner sendrom (AKS) hastaları dahil edildi. Obezite, kronik böbrek hastalığı, diabetes mellitus hastalığı olanlar dışlandı. Kontrol grubuna troponin değerleri yükselmeyen ve normal koroner anatomi tespit edilen 60 hasta dahil edildi. MI grubunda başvuru Ekg’sinde>2 mm st segment elevasyonu görülerek primer perkütan girişim yapılan 59 MI hastası değerlendirildi. Tüm hastalarda demografik bilgiler, hemogram, serum nesfatin, troponin, c-reaktif protein (CRP), lipid paneli ve diğer rutin biyokimyasal parametreler bakıldı. SPSS 22 istatistik paket programı kullanıldı. Bulgular: MI grubunda troponin, LDL, CRP, WBC değerleri anlamlı düzeyde yüksek izlendi (p<0,001). Nesfatin değerlerinin kontrol grubuna göre anlamlı düzeyde düşük olduğu görüldü (p<0.001). Erkek cinsiyetin MI grubunda ağırlıkta olduğu görüldü. MI grubundaki verilerde yapılan korelasyon analizinde nesfatin ile troponin, lipid profili, CRP ve WBC arasında pozitif veya negatif yönde anlamlı herhangi bir korelasyon ilişkisi görülmedi. Sonuç: Çalışmamızda, düşük serum nesfatin seviyelerinin MI ile ilişkili olabileceği gösterilmiş ve etyopatogenetik sebeplerden biri olabileceği desteklenmiştir. Artmış troponin, LDL, CRP ve WBC düzeyleri ile herhangi bir korelasyon ilişkisi tespit edilmemiştir. Bu ilişki, inflamatuar özellikleri ve hastalığın prognozunu göstermesi açısından destekleyici olmamıştır.
- Open Access
- 21 September 2022
- Published by Hacettepe University - Medical School in Acta Medica
- Vol. 53 (3) , 219-226
The Effect of Statin Use on In-Hospital Mortality in Covid-19 Patients
Objective: Our aim in this study was to determine whether statins with anti-inflammatory and antithrombotic properties reduce in-hospital mortality in Covid-19 patients. Materials and Methods: 1752 patients hospitalized with the diagnosis of Covid-19 between September and December 2020 were retrospectively analyzed. The patients were grouped according to statin use and their characteristics were compared. The parameters associated with mortality were examined. Results: For the patients, the median age was 64 years (53-74 interquartile range [IQR]), 804 (45.9%) were over the age of 65, 903 (51.5%) were male, 167 (9.5%) were using statins, and mortality developed in 381 (21.7%) of the patients. The multivariate logistic regression model was applied using statistically significant parameters in the univariate analysis of mortality development. The group using statins was included in the regression model because it was statistically borderline significant (p=0.052). According to this model; increased age (odds ratio (OR) =1.051, 95% confidence interval (CI) 1.039-1.063, p<0.001), male gender (OR=1.002, 95%CI 0.993-1.010, p=0.705), decrease in lymphocyte count (OR=0.452, 95%CI 0.337-0.607, p<0.001) increase in potassium level (OR=1.306, 95%CI 1.025-1.664, p=0.031), increase in aspartate transaminase (AST) level (OR=1.004, 95%CI 1.001-1.007, p=0.003), increase in D-dimer level (OR=1.000, 95%CI 1.000-1.000, p=0.011), increase in procalcitonin level (OR=1.027, 95%CI 1.000-1.053, p=0.046), increase in CRP level (OR=1.007, 95%CI 1.005-1.008, p<0.001), and the development of myocardial injury (OR=3.045, 95%CI 1.864-4.976, p<0.001) was found to be associated with increased mortality. Statin use (OR=1.221, 95% CI 0.759-1.966, p=0.410) was not associated with mortality. Conclusion: According to our study, statin use was not associated with an increase or decrease in-hospital mortality in patients hospitalized with a diagnosis of Covid-19.
- 21 September 2022
- Published by Hacettepe University - Medical School in Acta Medica
- Vol. 53 (3) , 219-226
Open AccessThe Effect of Statin Use on In-Hospital Mortality in Covid-19 Patients
Objective: Our aim in this study was to determine whether statins with anti-inflammatory and antithrombotic properties reduce in-hospital mortality in Covid-19 patients. Materials and Methods: 1752 patients hospitalized with the diagnosis of Covid-19 between September and December 2020 were retrospectively analyzed. The patients were grouped according to statin use and their characteristics were compared. The parameters associated with mortality were examined. Results: For the patients, the median age was 64 years (53-74 interquartile range [IQR]), 804 (45.9%) were over the age of 65, 903 (51.5%) were male, 167 (9.5%) were using statins, and mortality developed in 381 (21.7%) of the patients. The multivariate logistic regression model was applied using statistically significant parameters in the univariate analysis of mortality development. The group using statins was included in the regression model because it was statistically borderline significant (p=0.052). According to this model; increased age (odds ratio (OR) =1.051, 95% confidence interval (CI) 1.039-1.063, p<0.001), male gender (OR=1.002, 95%CI 0.993-1.010, p=0.705), decrease in lymphocyte count (OR=0.452, 95%CI 0.337-0.607, p<0.001) increase in potassium level (OR=1.306, 95%CI 1.025-1.664, p=0.031), increase in aspartate transaminase (AST) level (OR=1.004, 95%CI 1.001-1.007, p=0.003), increase in D-dimer level (OR=1.000, 95%CI 1.000-1.000, p=0.011), increase in procalcitonin level (OR=1.027, 95%CI 1.000-1.053, p=0.046), increase in CRP level (OR=1.007, 95%CI 1.005-1.008, p<0.001), and the development of myocardial injury (OR=3.045, 95%CI 1.864-4.976, p<0.001) was found to be associated with increased mortality. Statin use (OR=1.221, 95% CI 0.759-1.966, p=0.410) was not associated with mortality. Conclusion: According to our study, statin use was not associated with an increase or decrease in-hospital mortality in patients hospitalized with a diagnosis of Covid-19.
- Open Access
- 22 December 2021
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 12 (4) , 432-437
The relationship between symptoms and QRS duration in patients with idiopathic ventricular premature complex
Amaç: Prematüre ventriküler kompleksler (PVC' ler) en sık karşılaşılan aritmilerden biridir ve tedavi edilmediğinde dilate kardiyomyopati, ventriküler taşikardi gibi ciddi komplikasyonlara neden olmaktadır. Çalışmamızda İdiopatik premature ventrikeler komplexi (IPVC) olan hastalarda QRS süresi ile semptom arasındaki ilişkiyi araştırdık. Gereç ve yöntem: Ocak 2019 ile Mayıs 2019 tarihleri arasında on dokuz farklı merkezde kardiyoloji kliniklerine başvuran 24 saatlik holter izleminde 1.000'den fazla idiyopatik PVC'si ve normal QRS süresi olan 242 ardışık hastanın dahil edildiği çok merkezli, kesitsel bir çalışmadır. Hastaların semptomlarına göre semptomatik (n: 128) ve asemptomatik (n:114) olarak 2 gruba ayrılarak QRS süreleri arasındaki ilişki araştırıldı. Bulgular: 242 hastanın yaş ortalaması 51±13’ di ve %52,4 (127)’ ü erkek cinsiyetteki hastalardan oluşmaktaydı. Semptomatik IPVC grubunda asemptomatik IPVC gruba göre sinüs QRS süresi, PVC QRS süresi, coupling intervali ve prematürite indexi istatiksel anlamlılıkla daha yüksekti. Yapılan multivariete lojistik regresyon analizinde IPVC’ li hastalarda sinüs QRS süresi ile (odds ratio (OR) = 1.3, 95% confidence interval (CI) = 1.01-1.05, p=0.002) semptom arasında anlamlı ilişki saptandı. IPVC'li hastalarda sinüs QRS süresinin semptomları öngörmedeki gücünü göstermek için yapılan ROC analizinde Area Under Curve (AUC) değeri = 0,547 %95 GA: 0.454-0.640, p = 0.320 olarak saptandı (Şekil 1). Sonuç: IPVC’ li hastalarda; uzamış sinus QRS süresi olması hastaların semptomatik olmasında diğer parametrelerden daha üstün saptanmıştır Aim: Premature ventricular complexes are one of the most common arrhythmias and, when not treated, can cause serious complications such as dilated cardiomyopathy and ventricular tachycardia. In our study, we investigated the relationship between QRS duration and symptoms in patients with idiopathic premature ventricles complex (IPVC). Material and Methods: This is a multicenter, cross-sectional study involving 242 consecutive patients with more than 1,000 idiopathic PVC and normal QRS duration in 24-hour Holter follow-up who attended cardiology clinics in 18 different centers between January 2019 and May 2019. The relationship between the QRS durations was investigated by dividing the patients into 2 groups as symptomatic (n: 128) and asymptomatic (n: 114). Result: The average age of 242 patients was 51 ± 13 and 52.4% (127) of them were male patients. In the symptomatic IPVC group, sinus QRS duration, PVC QRS duration, coupling interval, and prematurity index were statistically significantly higher than the asymptomatic IPVC group. In the multivariate logistic regression analysis, a significant relationship was found between the sinus QRS duration (odds ratio (OR) = 1.3, 95% confidence interval (CI) = 1.01-1.05, p = 0.002) and symptoms in patients with IPVC. In the ROC analysis performed to show the power of sinus QRS duration in predicting symptoms in patients with IPVC, Area Under Curve (AUC) value was found as = 0.547 95% CI: 0.454-0.640, p = 0.320 (Figure 1). Conclusion: In patients with IPVC; The prolonged sinüs QRS duration was found to be superior to other parameters in patients being symptomatic.
- 22 December 2021
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 12 (4) , 432-437
Open AccessThe relationship between symptoms and QRS duration in patients with idiopathic ventricular premature complex
Amaç: Prematüre ventriküler kompleksler (PVC' ler) en sık karşılaşılan aritmilerden biridir ve tedavi edilmediğinde dilate kardiyomyopati, ventriküler taşikardi gibi ciddi komplikasyonlara neden olmaktadır. Çalışmamızda İdiopatik premature ventrikeler komplexi (IPVC) olan hastalarda QRS süresi ile semptom arasındaki ilişkiyi araştırdık. Gereç ve yöntem: Ocak 2019 ile Mayıs 2019 tarihleri arasında on dokuz farklı merkezde kardiyoloji kliniklerine başvuran 24 saatlik holter izleminde 1.000'den fazla idiyopatik PVC'si ve normal QRS süresi olan 242 ardışık hastanın dahil edildiği çok merkezli, kesitsel bir çalışmadır. Hastaların semptomlarına göre semptomatik (n: 128) ve asemptomatik (n:114) olarak 2 gruba ayrılarak QRS süreleri arasındaki ilişki araştırıldı. Bulgular: 242 hastanın yaş ortalaması 51±13’ di ve %52,4 (127)’ ü erkek cinsiyetteki hastalardan oluşmaktaydı. Semptomatik IPVC grubunda asemptomatik IPVC gruba göre sinüs QRS süresi, PVC QRS süresi, coupling intervali ve prematürite indexi istatiksel anlamlılıkla daha yüksekti. Yapılan multivariete lojistik regresyon analizinde IPVC’ li hastalarda sinüs QRS süresi ile (odds ratio (OR) = 1.3, 95% confidence interval (CI) = 1.01-1.05, p=0.002) semptom arasında anlamlı ilişki saptandı. IPVC'li hastalarda sinüs QRS süresinin semptomları öngörmedeki gücünü göstermek için yapılan ROC analizinde Area Under Curve (AUC) değeri = 0,547 %95 GA: 0.454-0.640, p = 0.320 olarak saptandı (Şekil 1). Sonuç: IPVC’ li hastalarda; uzamış sinus QRS süresi olması hastaların semptomatik olmasında diğer parametrelerden daha üstün saptanmıştır Aim: Premature ventricular complexes are one of the most common arrhythmias and, when not treated, can cause serious complications such as dilated cardiomyopathy and ventricular tachycardia. In our study, we investigated the relationship between QRS duration and symptoms in patients with idiopathic premature ventricles complex (IPVC). Material and Methods: This is a multicenter, cross-sectional study involving 242 consecutive patients with more than 1,000 idiopathic PVC and normal QRS duration in 24-hour Holter follow-up who attended cardiology clinics in 18 different centers between January 2019 and May 2019. The relationship between the QRS durations was investigated by dividing the patients into 2 groups as symptomatic (n: 128) and asymptomatic (n: 114). Result: The average age of 242 patients was 51 ± 13 and 52.4% (127) of them were male patients. In the symptomatic IPVC group, sinus QRS duration, PVC QRS duration, coupling interval, and prematurity index were statistically significantly higher than the asymptomatic IPVC group. In the multivariate logistic regression analysis, a significant relationship was found between the sinus QRS duration (odds ratio (OR) = 1.3, 95% confidence interval (CI) = 1.01-1.05, p = 0.002) and symptoms in patients with IPVC. In the ROC analysis performed to show the power of sinus QRS duration in predicting symptoms in patients with IPVC, Area Under Curve (AUC) value was found as = 0.547 95% CI: 0.454-0.640, p = 0.320 (Figure 1). Conclusion: In patients with IPVC; The prolonged sinüs QRS duration was found to be superior to other parameters in patients being symptomatic.
- Open Access
- 31 December 2020
- Published by Hacettepe University - Medical School in Acta Medica
- Vol. 51 (4) , 1-9
Electrolyte Imbalance and Its Effect on QTc Interval in Patients Hospitalized with COVID-19
Objective: Studies have shown that electrolyte abnormalities can be seen in Coronavirus disease 2019 (COVID-19) patients and are associated with the severity of the disease. We aimed to investigate the electrolyte imbalance such as hypocalcemia and hypokalemia in patients hospitalized with COVID-19 and its effect on the QTc interval. Materials and Methods: 185 hospitalized patients with COVID-19 whose diagnosis was confirmed by a real-time reverse transcriptase-polymerase chain reaction and/or Computed Tomography of the chest were included in the study. The potassium and calcium measurements on the admission and third day of hospitalization were recorded. The QTc interval measurement was performed on the admission (QTc-B) and the 3rd-day (QTc-AT) electrocardiography. Results: The median age was 43 (31-56 IQR) and 102 (55.1%) of patients were male. Median baseline potassium level was 4.0 mEq/L (3.7-4.3 IQR) and corrected calcium level was 8.48 mg/dl (8.24-8.73 IQR), whereas the 3rd-day median potassium level was 4.2 mEq/L (3.9-4.5 IQR) and corrected calcium level was 8.42 mg/dl (8.16-8.70 IQR).The median QTc-B interval was found as 427 ms (409-447 IQR) whereas the median QTc-AT interval was found as 438 ms (414-459 IQR). Median 9 ms (-5- 28 IQR) prolongation was observed in the QTc interval, which was statistically significant (p
- 31 December 2020
- Published by Hacettepe University - Medical School in Acta Medica
- Vol. 51 (4) , 1-9
Open AccessElectrolyte Imbalance and Its Effect on QTc Interval in Patients Hospitalized with COVID-19
Objective: Studies have shown that electrolyte abnormalities can be seen in Coronavirus disease 2019 (COVID-19) patients and are associated with the severity of the disease. We aimed to investigate the electrolyte imbalance such as hypocalcemia and hypokalemia in patients hospitalized with COVID-19 and its effect on the QTc interval. Materials and Methods: 185 hospitalized patients with COVID-19 whose diagnosis was confirmed by a real-time reverse transcriptase-polymerase chain reaction and/or Computed Tomography of the chest were included in the study. The potassium and calcium measurements on the admission and third day of hospitalization were recorded. The QTc interval measurement was performed on the admission (QTc-B) and the 3rd-day (QTc-AT) electrocardiography. Results: The median age was 43 (31-56 IQR) and 102 (55.1%) of patients were male. Median baseline potassium level was 4.0 mEq/L (3.7-4.3 IQR) and corrected calcium level was 8.48 mg/dl (8.24-8.73 IQR), whereas the 3rd-day median potassium level was 4.2 mEq/L (3.9-4.5 IQR) and corrected calcium level was 8.42 mg/dl (8.16-8.70 IQR).The median QTc-B interval was found as 427 ms (409-447 IQR) whereas the median QTc-AT interval was found as 438 ms (414-459 IQR). Median 9 ms (-5- 28 IQR) prolongation was observed in the QTc interval, which was statistically significant (p